What's Going On With Mirati Therapeutics Stock?
Portfolio Pulse from Erica Kollmann
Shares of Mirati Therapeutics, Inc. (NASDAQ:MRTX) are trading higher after several analysts updated their price targets and reports surfaced of a potential acquisition by Sanofi (NASDAQ:SNY). The stock is trading on heavy volume, exceeding its 100-day average.
October 06, 2023 | 3:16 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Mirati Therapeutics' stock is trading higher following updated price targets and potential acquisition reports. Trading volume is also higher than the 100-day average.
The stock price of Mirati Therapeutics is likely to increase in the short term due to the updated price targets by analysts and the potential acquisition by Sanofi. The high trading volume indicates strong investor interest.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEUTRAL IMPACT
Sanofi is reportedly considering the acquisition of Mirati Therapeutics, which could impact its stock price.
Sanofi's stock price could be impacted by the potential acquisition of Mirati Therapeutics. However, the impact is uncertain as the acquisition is not confirmed yet.
CONFIDENCE 70
IMPORTANCE 60
RELEVANCE 50